202 related articles for article (PubMed ID: 30981860)
1. M1 Muscarinic Receptor Activation Rescues β-Amyloid-Induced Cognitive Impairment through AMPA Receptor GluA1 Subunit.
Zhao LX; Chen MW; Qian Y; Yang QH; Ge YH; Chen HZ; Qiu Y
Neuroscience; 2019 Jun; 408():239-247. PubMed ID: 30981860
[TBL] [Abstract][Full Text] [Related]
2. M1 muscarinic receptor facilitates cognitive function by interplay with AMPA receptor GluA1 subunit.
Zhao LX; Ge YH; Xiong CH; Tang L; Yan YH; Law PY; Qiu Y; Chen HZ
FASEB J; 2018 Aug; 32(8):4247-4257. PubMed ID: 29509512
[TBL] [Abstract][Full Text] [Related]
3. M1 muscarinic receptors regulate the phosphorylation of AMPA receptor subunit GluA1
Zhao LX; Ge YH; Li JB; Xiong CH; Law PY; Xu JR; Qiu Y; Chen HZ
FASEB J; 2019 May; 33(5):6622-6631. PubMed ID: 30794430
[TBL] [Abstract][Full Text] [Related]
4. PKC and Ras are Involved in M1 Muscarinic Receptor-Mediated Modulation of AMPA Receptor GluA1 Subunit.
Chen MW; Zhu H; Xiong CH; Li JB; Zhao LX; Chen HZ; Qiu Y
Cell Mol Neurobiol; 2020 May; 40(4):547-554. PubMed ID: 31721013
[TBL] [Abstract][Full Text] [Related]
5. M1 muscarinic receptors facilitate hippocampus-dependent cognitive flexibility via modulating GluA2 subunit of AMPA receptors.
Xiong CH; Liu MG; Zhao LX; Chen MW; Tang L; Yan YH; Chen HZ; Qiu Y
Neuropharmacology; 2019 Mar; 146():242-251. PubMed ID: 30529302
[TBL] [Abstract][Full Text] [Related]
6. GPR40 receptor activation leads to CREB phosphorylation and improves cognitive performance in an Alzheimer's disease mouse model.
Khan MZ; Zhuang X; He L
Neurobiol Learn Mem; 2016 May; 131():46-55. PubMed ID: 26976092
[TBL] [Abstract][Full Text] [Related]
7. Zexieyin formula alleviates Alzheimer's disease via post-synaptic CaMKII modulating AMPA receptor: Involved in promoting neurogenesis to strengthen synaptic plasticity in mice hippocampus.
Sun Y; Zhang H; Liu R; Wang Y; Zhang X; Huang R; Zhu B; Wu H
Phytomedicine; 2024 Aug; 131():155802. PubMed ID: 38852473
[TBL] [Abstract][Full Text] [Related]
8. M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.
Fisher A; Pittel Z; Haring R; Bar-Ner N; Kliger-Spatz M; Natan N; Egozi I; Sonego H; Marcovitch I; Brandeis R
J Mol Neurosci; 2003; 20(3):349-56. PubMed ID: 14501019
[TBL] [Abstract][Full Text] [Related]
9. Naltrexone Facilitates Learning and Delays Extinction by Increasing AMPA Receptor Phosphorylation and Membrane Insertion.
Kibaly C; Kam AY; Loh HH; Law PY
Biol Psychiatry; 2016 Jun; 79(11):906-16. PubMed ID: 26049209
[TBL] [Abstract][Full Text] [Related]
10. Caspase-1/IL-1β represses membrane transport of GluA1 by inhibiting the interaction between Stargazin and GluA1 in Alzheimer's disease.
Gu X; Wu H; Xie Y; Xu L; Liu X; Wang W
Mol Med; 2021 Jan; 27(1):8. PubMed ID: 33509083
[TBL] [Abstract][Full Text] [Related]
11. AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease.
Fisher A; Brandeis R; Bar-Ner RH; Kliger-Spatz M; Natan N; Sonego H; Marcovitch I; Pittel Z
J Mol Neurosci; 2002; 19(1-2):145-53. PubMed ID: 12212772
[TBL] [Abstract][Full Text] [Related]
12. TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease.
Gao L; Tian M; Zhao HY; Xu QQ; Huang YM; Si QC; Tian Q; Wu QM; Hu XM; Sun LB; McClintock SM; Zeng Y
J Neurochem; 2016 Feb; 136(3):620-36. PubMed ID: 26577931
[TBL] [Abstract][Full Text] [Related]
13. Acute Effects of Muscarinic M1 Receptor Modulation on AβPP Metabolism and Amyloid-β Levels in vivo: A Microdialysis Study.
Welt T; Kulic L; Hoey SE; McAfoose J; Späni C; Chadha AS; Fisher A; Nitsch RM
J Alzheimers Dis; 2015; 46(4):971-82. PubMed ID: 25881909
[TBL] [Abstract][Full Text] [Related]
14. In vivo administration of extracellular cGMP normalizes TNF-α and membrane expression of AMPA receptors in hippocampus and spatial reference memory but not IL-1β, NMDA receptors in membrane and working memory in hyperammonemic rats.
Cabrera-Pastor A; Hernandez-Rabaza V; Taoro-Gonzalez L; Balzano T; Llansola M; Felipo V
Brain Behav Immun; 2016 Oct; 57():360-370. PubMed ID: 27189036
[TBL] [Abstract][Full Text] [Related]
15. miR-142 downregulation alleviates the impairment of spatial learning and memory, reduces the level of apoptosis, and upregulates the expression of pCaMKII and BAI3 in the hippocampus of APP/PS1 transgenic mice.
Fu CH; Han XY; Tong L; Nie PY; Hu YD; Ji LL
Behav Brain Res; 2021 Sep; 414():113485. PubMed ID: 34302879
[TBL] [Abstract][Full Text] [Related]
16. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
17. GluA1 subunit ubiquitination mediates amyloid-β-induced loss of surface α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
Guntupalli S; Jang SE; Zhu T; Huganir RL; Widagdo J; Anggono V
J Biol Chem; 2017 May; 292(20):8186-8194. PubMed ID: 28377502
[TBL] [Abstract][Full Text] [Related]
18. Treadmill exercise overcomes memory deficits related to synaptic plasticity through modulating ionic glutamate receptors.
Li B; Mao Q; Zhao N; Xia J; Zhao Y; Xu B
Behav Brain Res; 2021 Sep; 414():113502. PubMed ID: 34331969
[TBL] [Abstract][Full Text] [Related]
19. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
[TBL] [Abstract][Full Text] [Related]
20. Aβ peptide enhances GluA1 internalization via lipid rafts in Alzheimer's-related hippocampal LTP dysfunction.
Midorikawa R; Wakazono Y; Takamiya K
J Cell Sci; 2024 Apr; 137(8):. PubMed ID: 38668720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
